CLINICAL_TRIALS
trial_result
· 2012-01-20
Clinical Trial Update: Sorafenib for Imatinib/Sunitinib-failed GIST [Phase 2]
Summary
A Phase 2 trial evaluating sorafenib in patients with gastrointestinal stromal tumors that progressed after imatinib and sunitinib has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Samsung Medical Center | Conditions: Gastrointestinal Stromal Tumors | Phase 2 | Status: COMPLETED